Market Definition
NGS-based RNA Sequencing is used to protect against the intentional interference of electronic signals. This equipment can be used to protect against radio frequency interference (RFI), electromagnetic interference (EMI), or other types of signal interference. There are a variety of anti-jamming technologies that can be used, depending on the type of interference that is being protected against. For example, RFI jamming can be countered with frequency-hopping spread spectrum (FHSS) technology, while EMI jamming can be countered with pulse-code modulation (PCM) or other digital modulation techniques.
Market Outlook
The global NGS-based RNA Sequencing Market was valued at USD 2.8 Billion in 2022 and it is anticipated to grow up to USD 21.3 Billion by 2032, at a CAGR of 22.5% during the forecast period.
Advantages offered by NGS-based RNA sequencing such as it provides a sensitive, and accurate assay of gene expressions which is increasingly the method of choice for scientists researching on the transcriptome. Moreover, RNA sequencing based on NGS captures both known and novel features. Also, it can generate both qualitative and quantitative data, saving the research time. The market is anticipated to be driven by significant factors, including an increase in cancer incidence, government research grants, and molecular biology technical developments. Moreover, contrarily, large-scale whole-genome sequencing (WGS), one of the most preferred methods in agriculture, forensics, and biofuels, is now affordable and manageable for a typical researcher by next-generation sequencing (NGS). It enables researchers to sequence thousands of genomes in a single year or to study the whole human genome in a single sequencing session.
Technological advancements in next-generation Sequencing (NGS) by top players are another factor increasing the growth of the global NGS-based RNA sequencing market. Illumina introduced its iSeq 100 System, a semiconductor sequencing technology. Sequencing by synthesis (SBS) chemistry is combined with a semiconductor chip in semiconductor sequencing technology.
Restraining factors for NGS in clinical microbiology include unexplained antibiotic resistance, the inability to determine which organism is causing sickness, costs, and questionable clinical utility. The high cost of sequencing is a major barrier to the adoption of NGS. The technology is still relatively new and the costs have not yet come down to a level that is affordable for many laboratories. In addition, the lack of standardization in NGS protocols means that there is no agreed upon set of best practices for data collection and analysis. This lack of standardization makes it difficult to compare results from different laboratories and makes it difficult to reproduce results.The need for skilled personnel is another challenge facing the NGS market. The technology is complex and requires a high level of technical expertise to operate. In addition, the data generated by NGS experiments can be very large and complex, making it difficult to analyze and interpret without the help of bioinformatics experts.
Request Sample: https://www.globalinsightservices.com/inquiry-before-buying/GIS10519/
Research Objectives
- Estimates and forecast the overall market size for the total market, across product, service type, type, end-user, and region
- Detailed information and key takeaways on qualitative and quantitative trends, dynamics, business framework, competitive landscape, and company profiling
- Identify factors influencing market growth and challenges, opportunities, drivers and restraints
- Identify factors that could limit company participation in identified international markets to help properly calibrate market share expectations and growth rates
- Trace and evaluate key development strategies like acquisitions, product launches, mergers, collaborations, business expansions, agreements, partnerships, and R&D activities
- Thoroughly analyze smaller market segments strategically, focusing on their potential, individual patterns of growth, and impact on the overall market
- To thoroughly outline the competitive landscape within the market, including an assessment of business and corporate strategies, aimed at monitoring and dissecting competitive advancements.
- Identify the primary market participants, based on their business objectives, regional footprint, product offerings, and strategic initiatives
Market Segmentation
The report analyses the global NGS-based RNA Sequencing Market based on product & service, technology, application, and region.
Global NGS-based RNA Sequencing Market by Product & Services
The global NGS-based RNA sequencing market based on products & services is grouped into sample preparation, platforms & consumables, services, and data analysis. In 2021, the platforms and consumables segment held the greatest market share. This expansion is due to the ongoing technological advancements in the biotech industry. The rapidly expanding availability of innovative and affordable RNA sequencing systems, including library preparation, accelerates the segment growth. In addition, the services segment is predicted to expand at a high CAGR over the projection period due to the increasing use of services like RNA isolation, library preparation, sequencing, and data analysis as part of the full sample-to-insight solutions.
Global NGS-based RNA Sequencing Market by Technology
Based on technology, the global NGS-based RNA sequencing market is grouped into sequencing by synthesis, ion semiconductor sequencing, nanopore sequencing, and single-molecule real-time sequencing. The sequencing by synthesis (SBS) segment holds most of the market share. Sequencing by synthesis (SBS) is one of the widely used technology. Moreover, SBS provides robust performance and data quality; it provides unbiased coverage across the genome. Also SBS chemistry produces extremely precise sequencing using a single base extension and competitive nucleotide addition. Many top players, such as Illumina Inc. use the sequencing by synthesis (SBS) technique in their NGS systems, making it more affordable.
Global NGS-based RNA Sequencing Market by Application
The global NGS-based RNA sequencing market is segmented on application into De novo, epigenetics, and small RNA. De novo sequencing is the process of sequencing a novel genome in the absence of an alignment table reference sequence. De novo assembly of RNA-seq data enables the study of the transcriptome, whether data are collected from a single organism or from a mixed sample, as in meta-transcriptomics investigations. NGS-based RNA sequencing in De Novo also helps clarify similar or repetitive regions for accurate de novo assembly. De novo also provides accurate data for the genome mapping of novel organisms.
Geographical Analysis of Global NGS-based RNA Sequencing Market
Regionally, the global NGS-based RNA Sequencing Market has been segmented into North America, Europe, Asia Pacific, and the Rest Of The World. North America holds the leading position. The demand for early diagnosis of diseases like cancer in the region has increased as a result of the development of next-generation sequencing, which has decreased the cost of genome sequencing, a crucial stage in a gene expression study. The presence of major companies like Illumina, Thermo Fisher Scientific, and PerkinElmer and the increased focus on genome mapping projects have significantly benefited the growth of the next-generation sequencing industry in North America. According to estimates by The National Institutes of Health’s (NIH) Human Genome Research Institute (NHGRI) in March 2022, the organization supports genomic research with such generous funding. According to statistics, the United States has invested more than any other nation in genomics research over the past ten years, amounting to 35% of all public funding received globally.
Major Players
The key players in the NGS-based RNA Sequencing Market are Agilent Technologies, Inc. , BGI Group, Eurofins Scientific SE, Genewiz, Inc. , F. Hoffman- La Roche AG, Thermo Fisher Scientific , Zymo Research Corporation, Psomagen, Inc. , Hamilton Company , Qiagen N.V. among others.
Request Discounted Pricing@ https://www.globalinsightservices.com/request-special-pricing/GIS10519/
Research Scope
- Scope – Highlights, Trends, Insights. Attractiveness, Forecast
- Market Sizing – Product Type, End User, Offering Type, Technology, Region, Country, Others
- Market Dynamics – Market Segmentation, Demand and Supply, Bargaining Power of Buyers and Sellers, Drivers, Restraints, Opportunities, Threat Analysis, Impact Analysis, Porters 5 Forces, Ansoff Analysis, Supply Chain
- Business Framework – Case Studies, Regulatory Landscape, Pricing, Policies and Regulations, New Product Launches. M&As, Recent Developments
- Competitive Landscape – Market Share Analysis, Market Leaders, Emerging Players, Vendor Benchmarking, Developmental Strategy Benchmarking, PESTLE Analysis, Value Chain Analysis
- Company Profiles – Overview, Business Segments, Business Performance, Product Offering, Key Developmental Strategies, SWOT Analysis
Buy your copy here: https://www.globalinsightservices.com/checkout/single_user/GIS10519/
With Global Insight Services, you receive:
- 10-year forecast to help you make strategic decisions
- In-depth segmentation which can be customized as per your requirements
- Free consultation with lead analyst of the report
- Infographic excel data pack, easy to analyze big data
- Robust and transparent research methodology
- Unmatched data quality and after sales service
Contact Us:
Global Insight Services LLC
16192, Coastal Highway, Lewes DE 19958
E-mail: [email protected]
Phone: +1-833-761-1700
Website: https://www.globalinsightservices.com/
About Us:
Global Insight Services (GIS) is a leading multi-industry market research firm headquartered in Delaware, US. We are committed to providing our clients with highest quality data, analysis, and tools to meet all their market research needs. With GIS, you can be assured of the quality of the deliverables, robust & transparent research methodology, and superior service.